Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomes

Saudi Pharmaceutical Journal

Volumn 18, Issue 4, 2010, Pages 217-224

  El Nesr, Ola H ^a   Yahiya, Soad A ^b   El Gazayerly, Omaima N ^b  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Fluconazole; Freeze drying; Multilamellar liposomes; Ophthalmic; Stability

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; CRYOPROTECTIVE AGENT; DICETYL PHOSPHATE; FLUCONAZOLE; LIPOSOME; OCTADECYLAMINE; TREHALOSE;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; FREEZE DRYING; IN VITRO STUDY; LIPOSOMAL DELIVERY; PARTICLE SIZE;

EID: 79960184966     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2010.07.003     Document Type: Article

References (34)

1. Abbasoglu O.E., Hosal B.M., Sener B., Erdemoglu N., Gursel E. Penetration of topical fluconazole into human aqueous humor. Exp. Eye Res. 2001, 72:147-151.
2. Ambrosini A., Bossi G., Dante S., Dubinib G., Leone L., Bossi M., Zolese G. Lipid-drug interaction: thermodynamic and structural effects of antimicotic fluconazole on DPPC liposomes. Chem. Phys. Lipids 1998, 95:37-47.
3. Armengol X., Estelrich J. Physical stability of different liposome compositions obtained by extrusion method. J. Microencapsulation 1995, 12(5):525-535.
4. Assadullahi T.P., Hamid K., Hider R.C. In-vitro stability of liposomes in the presence of polymers, trehalose and sodium taurocholate. J. Microencapsulation 1992, 9:317-327.
5. Behrens-Baumann W., Klinge B., Ruchel R. Topical fluconazole for experimental candida keratits in rabbits. Br. J. Ophthalmol. 1990, 74:40-42.
6. Clares B., Gallardo V., Medina M.M., Ruiz M.A. Multilamellar liposomes of triamcinolone acetonide: preparation, stability, and characterization. J. Lipos. Res. 2009, 19(3):197-206.
7. Crowe L., Crowe J., Rudolph A., Womersley C., Appel L. Preservation of freeze-dried liposomes by trehalose. Arch. Biochem. Biophys. 1985, 242:240-247.
8. Dharma S., Fishman P., Peyman G. A preliminary study of corneal penetration of 125I-labeled idoxuridine liposomes. Acta Ophthalmol. 1986, 64:298-301.
9. Du Plessis J., Ramachandran C., Weiner N., Muller D. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int. J. Pharm. 1996, 127:273-278.
10. Fresta M., Puglisi G., Panico A., Di Marco S., Mazzone G. CDP-choline entrapment and release from multilamellar and reverse-phase evaporation liposomes. Drug Dev. Ind. Pharm. 1993, 19:559-585.
11. Gulati M., Grover M., Singh M., Singh S. Study of azathioprine encapsulation into liposomes. J. Microencapsulation 1998, 15:485-494.
12. Habib F.S., Fouad E.A., Abdel-Rhaman M.S., Fathalla D. Liposomes as an ocular delivery system of fluconazole: in-vitro studies. Acta opthalmol. J 2009, 10.1111/j.1755-3768.2009.01584.
13. Klotz S.A., Penn C.C., Negvesky G.J., Butrus S.I. Fungal and parasitic infections of the eye. Clin. Microbiol. Rev. 2000, 13:662-685.
14. Law S.L., Hung H.Y. Properties of acyclovir-containing liposomes for potential ocular delivery. Int. J. Pharm. 1998, 161:253-259.
15. Law S.L., Shih C. Characterization of calcitonin-containing liposomes formulations for intranasal delivery. J. Microencapsulation 2001, 18:211-221.
16. Lee V.H.L. Precorneal, corneal and postcorneal factors. Ophthalmic Drug Delivery Systems 1993, 59-82. Marcel Dekker, New York. A.K. Mitra (Ed.).
17. Li Z., Gallet O., Gaillard C., Lemoine R., Delrot S. The sucrose carrier of the plant plasmalemma III. Partial purification and reconstitution of active sucrose transport in liposomes. Biochem. Biophys. Acta 1992, 1103:259-267.
18. Madden T.D., Boman N. Lyophilization of liposomes. Liposomes Rational Design 1999, 261-307. Marcel Dekker, Inc., New York and Basel. A.S. Janoff (Ed.).
19. Mezei M. Liposomes as penetration promoters and localizers of topically applied drugs. Drug Permeation Enhancement, Theory and Applications 1994, 171-191. Marcel Dekker, New York. D.S. Hsieh (Ed.).
20. Nagarsenker M.S., londh V.Y., Nadkarni G.D. Preparation and evaluation of liposomes of indomethacin. Drug Dev. Ind. Pharm. 2002, 26:313-321.
21. Narendran N., Balasubramaniam B., Johnson E., Dick A., Mayer E. Five-year retrospective review of guideline-based management of fungal endophthalmitis. Acta Ophthalmol. 2008, 86:525-532.
22. Patel V., Misra A. Encapsulation and stability of clofazimine liposomes. J. Microencapsulation 1999, 16(3):357-367.
23. Perugini P., Pavanetto F. Liposomes containing boronophenylalanine for boron neutron capture therapy. J. Microencapsulation 1998, 15:473-483.
24. Price M.F., LaRocco M.T., Gentry L.O. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 1994, 38:1422-1424.
25. Sharma A., Sharma U. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 1997, 154:123-140.
26. Singh M., Singh M.P., Maiti S.N., Gandhi A., Micetich R.G., Atwal H. Preparations of liposomal fluconazole and their in vitro antifungal activity. J. Microencapsulation 1993, 10:229-236.
27. Singla A.K., Chawla M., Singh A. Potential application of carbomer in oral mucoadhesive controlled drug delivery system. Drug Dev. Ind. Pharm. 2000, 26:913-924.
28. Sun W., Leopold A., Crowe L., Crowe J. Stability of dry liposomes in sugar glasses. Biophys. J. 1996, 70:1769-1776.
29. Vemuri S., Rhodes C. Encapsulation of a water-soluble drug in a liposome preparation: removal of free drug by washing. Drug Dev. Ind. Pharm. 1995, 21(11):1329-1338.
30. Vemuri S., Rhodes C. Development and validation of a drug release rate method for a water-soluble drug in a liposome preparation. Drug Dev. Ind. Pharm. 1995, 21(11):1353-1364.
31. Venuri S., Yu C., DeGroot J.S., Wangsatornthnakun V., Venkataram S. Effect of sugars on freeze-thaw and lyophilization of liposomes. Drug Dev. Ind. Pharm. 1991, 17:327-348.
32. Xu Quanyun A., Lawrence A. Stability-indicating HPLC Methods for Drug Analysis 1999, Pharmaceutical Press, London, England, pp. 174-177.
33. Yee R.W., Cheng C.J., Meenakshi S., Ludden T.M., Wallace J.E., Rinaldi M.G. Ocular penetration and pharmacokinetics of topical fluconazole. Cornea 1997, 16:64-71.
34. Yilmaz S., Maden A. Severe fungal keratitis treated with subconjunctival fluconazole. Am. J. Ophthalmol. 2005, 140:454-458.